Rxwire
Deals & business · first seen 10h ago, updated 10h ago

Earendil’s AI platform lands $1.5B Genentech collaboration

1 outlet Roche

In its second major collaboration announced this year, AI-focused Earendil Labs is pairing up with Roche Holding AG’s Genentech unit in a discovery deal aimed at developing bispecific antibody therapeutics in oncology.

Summary from BioWorld Articles.

Coverage 1 article · 1 outlet

  1. BioWorld Articles
    Earendil’s AI platform lands $1.5B Genentech collaboration